San Francisco Sentry Investment Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $22K | Sell |
262
-4
| -2% | -$336 | 0.01% | 461 |
|
|
2021
Q1 | $20K | Hold |
266
| – | – | 0.01% | 492 |
|
|
2020
Q4 | $23K | Sell |
266
-22
| -8% | -$1.9K | 0.01% | 447 |
|
|
2020
Q3 | $22K | Sell |
288
-7
| -2% | -$535 | 0.01% | 416 |
|
|
2020
Q2 | $36K | Sell |
295
-2
| -0.7% | -$244 | 0.02% | 360 |
|
|
2020
Q1 | $25K | Sell |
297
-22
| -7% | -$1.85K | 0.02% | 357 |
|
|
2019
Q4 | $27K | Hold |
319
| – | – | 0.01% | 441 |
|
|
2019
Q3 | $21K | Sell |
319
-7
| -2% | -$461 | 0.01% | 465 |
|
|
2019
Q2 | $28K | Sell |
326
-84
| -20% | -$7.22K | 0.01% | 432 |
|
|
2019
Q1 | $36K | Buy |
410
+177
| +76% | +$15.5K | 0.02% | 419 |
|
|
2018
Q4 | $20K | Sell |
233
-20
| -8% | -$1.72K | 0.01% | 466 |
|
|
2018
Q3 | $24K | Buy |
253
+231
| +1,050% | +$21.9K | 0.01% | 468 |
|
|
2018
Q2 | $2K | Hold |
22
| – | – | ﹤0.01% | 689 |
|
|
2018
Q1 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 835 |
|
|
2017
Q3 | – | Sell |
-50
| Closed | -$5K | – | 915 |
|
|
2017
Q2 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 595 |
|